Anlotinib or Penpulimab in Combination With RAI for DTC

NCT04952493 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Thyroid Cancer

Interventions

DRUG: Anlotinib hydrochloride
DRUG: Sodium Iodide I 131
DRUG: Penpulimab

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]